tazarotene

Generic: tazarotene

Labeler: padagis israel pharmaceuticals ltd
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tazarotene
Generic Name tazarotene
Labeler padagis israel pharmaceuticals ltd
Dosage Form CREAM
Routes
TOPICAL
Active Ingredients

tazarotene .5 mg/g

Manufacturer
Padagis Israel Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 45802-706
Product ID 45802-706_27ddf7ba-f3a2-43ff-83a5-e7c95b355028
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217075
Listing Expiration 2026-12-31
Marketing Start 2024-09-09

Pharmacologic Class

Established (EPC)
retinoid [epc]
Chemical Structure
retinoids [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 45802706
Hyphenated Format 45802-706

Supplemental Identifiers

RxCUI
314268
UNII
81BDR9Y8PS
NUI
N0000175607 M0018962

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tazarotene (source: ndc)
Generic Name tazarotene (source: ndc)
Application Number ANDA217075 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (45802-706-94) / 30 g in 1 TUBE
  • 1 TUBE in 1 CARTON (45802-706-96) / 60 g in 1 TUBE
source: ndc

Packages (2)

45802-706-94 1 TUBE in 1 CARTON (45802-706-94) / 30 g in 1 TUBE 45802-706-96 1 TUBE in 1 CARTON (45802-706-96) / 60 g in 1 TUBE

Ingredients (1)

tazarotene (.5 mg/g)

Linked Drug Pages (1)

TAZAROTENE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "27ddf7ba-f3a2-43ff-83a5-e7c95b355028", "openfda": {"nui": ["N0000175607", "M0018962"], "unii": ["81BDR9Y8PS"], "rxcui": ["314268"], "spl_set_id": ["df5d65de-0693-4fd2-b335-f04ab1e201e7"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (45802-706-94)  / 30 g in 1 TUBE", "package_ndc": "45802-706-94", "marketing_start_date": "20240909"}, {"sample": false, "description": "1 TUBE in 1 CARTON (45802-706-96)  / 60 g in 1 TUBE", "package_ndc": "45802-706-96", "marketing_start_date": "20240909"}], "brand_name": "TAZAROTENE", "product_id": "45802-706_27ddf7ba-f3a2-43ff-83a5-e7c95b355028", "dosage_form": "CREAM", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "45802-706", "generic_name": "tazarotene", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAZAROTENE", "active_ingredients": [{"name": "TAZAROTENE", "strength": ".5 mg/g"}], "application_number": "ANDA217075", "marketing_category": "ANDA", "marketing_start_date": "20240909", "listing_expiration_date": "20261231"}